Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

Taconic Announces Sponsorship of 2017 Translational Microbiome Conference

Leading Discussions on Key Animal Model Considerations for Studying the Microbiome Hudson, NY — March 13, 2017 - Taconic Biosciences, the only commercial provider of germ free rodent models, announced that it will sponsor the Translational Microbiome Conference to be held in Boston April 11-13, 2017. This three-day conference will focus on the potential for translational intervention in microbiome research and the challenges associated with successful microbiome...

Read More

Taconic Biosciences Announces Expansion of Key Immunodeficient Animal Model Production

Hudson, NY — March 9, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced that effective March 1, 2017 it will expand the offering of two key immunodeficient mouse models, Rag2/Il2rg double knockout and fully congenic C57BL/6NTAC Rag2 knockout. This expansion capitalizes on the duel demands for European production of immunodeficient models as well as the need for increasingly stringent...

Read More

Assessing Host-Microbiota Relationships

Genetic Engineering & Biotechnology News spotlights Taconic's Alexander Maue, PhD who is an expert on the microbiome: "Microbes have long had the knack of making themselves at home. In fact, these versatile and adaptable life forms are known to have preceded us by billions of years, exploiting virtually every niche on the planet. Microbes will in all likelihood survive us, too. In the meantime, they are happy...

Read More

Targeting Gut Bacteria May Be The Key To Preventing Alzheimer's

Huffington Post speaks of a new study which proposes a link between the brain and how a gut-healthy diet could help prevent the development of Alzheimer's disease: "Mounting research continues to show the links between the health of the gut and that of the brain. Now, a new study from Lund University in Sweden finds that unhealthy intestinal flora can accelerate the development of Alzheimer's disease. The...

Read More

Taconic Biosciences Generates Vici Syndrome Mouse Model

CRISPR Accelerates Availability of Vital Research Tool Hudson, NY - February 17, 2017 - Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, announced it has generated a novel mouse model of Vici syndrome for use by two investigators studying this rare disease. As a corporate sponsor of the Rare Disease Science Challenge: BeHEARD, hosted by the Rare Genomics Institute, Taconic donated model...

Read More

Mouse model program looks to speed drug discovery

Outsourcing-Pharma discusses the EZcohort™ program launched at Taconic Biosciences: "According to the company, the EZcohort™ program was developed in response to "a need for speed and predictability in drug discovery." Dr. Michael Seiler, portfolio director, Commercial Genetically Engineered Models, Taconic Biosciences, told us the company has "innovated in the transactional space." "Instead of requiring materials transfer agreements, as many repository vendors do, we sell these under a...

Read More

Taconic Biosciences Launches New EZcohort™ Program Improving Access to Mouse Models

Hudson, NY - February 8, 2017 - Taconic Biosciences, a global leader in genetically engineered murine models and associated services, announced the launch of the EZcohort™ program, providing researchers faster and easier access to unique mouse models. In response to the need for speed and predictability in drug discovery, the EZcohort™ program leverages simplified legal documentation and common cohort sizes, allowing researchers to easily access unique cryopreserved...

Read More

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

Taconic was featured in the Journal of Pharmacology and Experimental Therapeutics, in which their knock-in mice were used: "Allosteric potentiators amplify the sensitivity of physiologic control circuits, a mode of action that could provide therapeutic advantages. This hypothesis was tested with the dopamine D1 receptor potentiator DETQ [2-(2,6-dichlorophenyl)-1-((1S,3R)-3-(hydroxymethyl)-5-(2-hydroxypropan-2-yl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one]. In human embryonic kidney 293 (HEK293) cells expressing the human D1 receptor, DETQ induced a 21-fold leftward shift in...

Read More

Rebalancing gut microbiome lengthens survival in mouse model of ALS

Medical Xpress discusses how researchers using a mouse model of ALS have found ways to help correct gut microbiome imbalance symptoms, which stem from ALS: "A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS - a progressive, neurodegenerative disease. Researchers at the University of Illinois at Chicago College of Medicine report that in a mouse...

Read More

Microbiome Science Could Bring a Revolution in Medical Care

NBC News talks over evolving Microbiome science and how it is impacting medical care: "The human body is made up of roughly 10 trillion cells. That's a huge number, but it's dwarfed by the 40 trillion or so bacterial cells that live on and inside the body. In recent years, scientists have learned that our bacteria -- known collectively as the microbiome -- are intimately involved with...

Read More